Endo Pharmaceuticals Balance Sheet
View: Annual | Quarterly
| Assets | Dec 08 | Dec 07 | Dec 06 |
|---|---|---|---|
| Current Assets | |||
| Cash | 775.7 | 350.3 | 628.1 |
| Net Receivables | 247.9 | 249.8 | 279.2 |
| Inventories | 80.7 | 69.2 | 62.1 |
| Other Current Assets | 79.4 | 396.1 | 66.6 |
| Total Current Assets | 1,183.7 | 1,065.4 | 1,036.0 |
| Net Fixed Assets | 44.4 | 44.9 | 36.6 |
| Other Noncurrent Assets | 728.6 | 592.3 | 324.1 |
| Total Assets | 1,956.6 | 1,702.6 | 1,396.7 |
| Liabilities and Shareholder's Equity | Dec 08 | Dec 07 | Dec 06 |
| Current Liabilities | |||
| Accounts Payable | 160.5 | 178.9 | 122.6 |
| Short-Term Debt | -- | 15.0 | -- |
| Other Current Liabilities | 226.0 | 203.1 | 215.5 |
| Total Current Liabilities | 386.5 | 397.0 | 338.1 |
| Long-Term Debt | -- | 0.5 | -- |
| Other Noncurrent Liabilities | 442.4 | 12.9 | 17.6 |
| Total Liabilities | 828.9 | 410.3 | 355.7 |
|
Shareholder's Equity | |||
| Preferred Stock Equity | 0.0 | 0.0 | 0.0 |
| Common Stock Equity | 1,127.7 | 1,292.3 | 1,041.0 |
| Total Equity | 1,127.7 | 1,292.3 | 1,041.0 |
| Shares Outstanding (mil.) | 117.3 | 117.3 | 117.3 |
© 2009 Morningstar, Inc. Financial Data provided by
